SPP1 and myeloid sarcoma: Significant difference in CSF levels of OPN exists between individuals with MS and the combined group of HC and NOND, showing higher levels in the MS group (Figure 1C); however, when comparing OPN levels between MS and patients with OND, this significant difference disappears (Figure 1A).